The role of anti-IgE in managing difficult-to-treat or severe asthma.
Until recently, treatment options for those with severe or difficult-to-treat asthma have been restricted to the use of beta 2-agonists and corticosteroids. It has been increasingly recognised that such patients need a new approach. This article discusses how anti-immunoglobulin E treatment could contribute to the successful management of patients with this condition.